Eric Wei
CIK 1368570 · last filed 2017-02-08
Eric Wei is a corporate insider who has filed 31 SEC Form 4 insider transactions across 3 companies since 2009. The most recent filing shows the insider sold $31.4K of CLBS on Feb 8, 2017. Across all open-market trades the lifetime net is +$4.1M, making them a net buyer over the disclosed history. 16 SEC filings were submitted jointly with RimAsia Capital Partners GP, L.P.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NBS.WS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
16 CHAOWAI DISTRICT
BEIJING, F4 100020
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LISATA THERAPEUTICS, INC. (CLBS) Delisted | Director | 11,769 | $6.40 | $75.3K | -$222.6K | 10 | 2017-02-08 |
| LISATA THERAPEUTICS, INC. (NBS) Delisted | Director | 2,144,988 | — | — | -$703.3K | 13 | 2015-06-04 |
| LISATA THERAPEUTICS, INC. (NBS.WS) Delisted | Director | 22,545,180 | — | — | $5.00M | 8 | 2012-07-03 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-02-08 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Sell (S) | −6,575 | -$31.4K | EDGAR |
| 2017-02-06 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Sell (S) | −8,425 | -$38.8K | EDGAR |
| 2017-01-31 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Grant (A) | +1,650 | $0 | EDGAR |
| 2016-11-25 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Sell (S) | −500 | -$2.1K | EDGAR |
| 2016-07-05 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Sell (S) | −87,500 | -$52.8K | EDGAR |
| 2016-06-27 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Sell (S) | −22,698 | -$12.5K | EDGAR |
| 2016-06-23 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Grant (A) | +7,500 | $0 | EDGAR |
| 2016-06-07 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Sell (S) | −77,302 | -$42.5K | EDGAR |
| 2016-06-06 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Sell (S) | −77,302 | -$42.5K | EDGAR |
| 2016-01-27 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Grant (A) | +9,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.